These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 35476024)
1. The Impact of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on Substance Use in the United States. Ross JA; Malone PK; Levy S Clin Infect Dis; 2022 Aug; 75(Suppl 1):S81-S85. PubMed ID: 35476024 [TBL] [Abstract][Full Text] [Related]
2. Substance use during the COVID-19 pandemic: What is really happening? Mellos E; Paparrigopoulos T Psychiatriki; 2022 Mar; 33(1):17-20. PubMed ID: 35255473 [TBL] [Abstract][Full Text] [Related]
3. Impact of the COVID-19 Pandemic on Youth Substance Use and Substance-Related Risk Factors and Outcomes: Implications for Prevention, Treatment, and Policy. Hammond CJ; Van Eck K; Adger H Pediatr Clin North Am; 2024 Aug; 71(4):653-669. PubMed ID: 39003008 [TBL] [Abstract][Full Text] [Related]
4. The Opioid Epidemic Within the COVID-19 Pandemic: Drug Testing in 2020. Niles JK; Gudin J; Radcliff J; Kaufman HW Popul Health Manag; 2021 Feb; 24(S1):S43-S51. PubMed ID: 33031013 [TBL] [Abstract][Full Text] [Related]
5. The Effects of the COVID-19 Pandemic on the Risk of Youth Substance Use. Richter L J Adolesc Health; 2020 Oct; 67(4):467-468. PubMed ID: 32773298 [No Abstract] [Full Text] [Related]
6. The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study. Otiashvili D; Mgebrishvili T; Beselia A; Vardanashvili I; Dumchev K; Kiriazova T; Kirtadze I Harm Reduct J; 2022 Mar; 19(1):25. PubMed ID: 35264181 [TBL] [Abstract][Full Text] [Related]
7. Substance Use Among Youth During the COVID-19 Pandemic: a Systematic Review. Layman HM; Thorisdottir IE; Halldorsdottir T; Sigfusdottir ID; Allegrante JP; Kristjansson AL Curr Psychiatry Rep; 2022 Jun; 24(6):307-324. PubMed ID: 35476186 [TBL] [Abstract][Full Text] [Related]
8. Early Adolescent Substance Use Before and During the COVID-19 Pandemic: A Longitudinal Survey in the ABCD Study Cohort. Pelham WE; Tapert SF; Gonzalez MR; McCabe CJ; Lisdahl KM; Alzueta E; Baker FC; Breslin FJ; Dick AS; Dowling GJ; Guillaume M; Hoffman EA; Marshall AT; McCandliss BD; Sheth CS; Sowell ER; Thompson WK; Van Rinsveld AM; Wade NE; Brown SA J Adolesc Health; 2021 Sep; 69(3):390-397. PubMed ID: 34452728 [TBL] [Abstract][Full Text] [Related]
9. Excess Fatal Overdoses in the United States During the COVID-19 Pandemic by Geography and Substance Type: March 2020-August 2021. Chandra J; Charpignon ML; Bhaskar A; Therriault A; Chen YH; Mooney A; Dahleh MA; Kiang MV; Dominici F Am J Public Health; 2024 Jun; 114(6):599-609. PubMed ID: 38718338 [No Abstract] [Full Text] [Related]
10. Challenges and opportunities during the COVID-19 pandemic: Treating patients for substance use disorders during the perinatal period. Jones HE; Hairston E; Lensch AC; Marcus LK; Heil SH Prev Med; 2021 Nov; 152(Pt 2):106742. PubMed ID: 34302836 [TBL] [Abstract][Full Text] [Related]
11. Changes in characteristics of drug overdose death trends during the COVID-19 pandemic. DiGennaro C; Garcia GP; Stringfellow EJ; Wakeman S; Jalali MS Int J Drug Policy; 2021 Dec; 98():103392. PubMed ID: 34325184 [TBL] [Abstract][Full Text] [Related]
12. The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public health surveillance data. Imtiaz S; Nafeh F; Russell C; Ali F; Elton-Marshall T; Rehm J Subst Abuse Treat Prev Policy; 2021 Nov; 16(1):87. PubMed ID: 34844624 [TBL] [Abstract][Full Text] [Related]
13. The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months. Bennett AS; Townsend T; Elliott L Int J Drug Policy; 2022 Mar; 101():103554. PubMed ID: 34911010 [TBL] [Abstract][Full Text] [Related]
14. Medicaid expansion and drug overdose mortality during the COVID-19 pandemic in the United States. Auty SG; Griffith KN Drug Alcohol Depend; 2022 Mar; 232():109340. PubMed ID: 35131533 [TBL] [Abstract][Full Text] [Related]
15. Changes in Emergency Medical Services Before and During the COVID-19 Pandemic in the United States, January 2018-December 2020. Handberry M; Bull-Otterson L; Dai M; Mann NC; Chaney E; Ratto J; Horiuchi K; Siza C; Kulkarni A; Gundlapalli AV; Boehmer TK Clin Infect Dis; 2021 Jul; 73(Suppl 1):S84-S91. PubMed ID: 33956123 [TBL] [Abstract][Full Text] [Related]
16. Converging public health crises: substance use during the coronavirus disease 2019 pandemic. Striley CW; Hoeflich CC Curr Opin Psychiatry; 2021 Jul; 34(4):325-331. PubMed ID: 34001699 [TBL] [Abstract][Full Text] [Related]
17. [Consequences of the COVID-19 pandemic for people with schizophrenia, dementia and substance use disorders]. Adorjan K; Haussmann R; Rauen K; Pogarell O Nervenarzt; 2021 Jun; 92(6):571-578. PubMed ID: 33779773 [TBL] [Abstract][Full Text] [Related]
18. Safer opioid distribution in response to the COVID-19 pandemic. Tyndall M Int J Drug Policy; 2020 Sep; 83():102880. PubMed ID: 32739148 [TBL] [Abstract][Full Text] [Related]
19. Trends in Substance-Related Visits Among Youth to US Children's Hospitals, 2016-2021: An Analysis of the Pediatric Health Information System Database. Ball A; Hadland S; Rodean J; Hall M; Mendoza J; Ahrens K J Adolesc Health; 2024 Jul; 75(1):76-84. PubMed ID: 38530681 [TBL] [Abstract][Full Text] [Related]
20. A Descriptive Comparison of Substance Use Services in Recovery and Isolation Sites for People Experiencing Homelessness During the COVID-19 Pandemic, Boston and Toronto. Harris MTH; Young S; Barocas J; Bayoumi AM; Caudarella A; Laurence G; Tomanovich M; Komaromy M Public Health Rep; 2021; 136(5):532-537. PubMed ID: 34269625 [No Abstract] [Full Text] [Related] [Next] [New Search]